You have 9 free searches left this month | for more free features.

secondary myelodysplastic syndromes

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

Recruiting
  • Secondary Myelodysplastic Syndrome
  • Therapy-Related Myelodysplastic Syndrome
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

Completed
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Jan 12, 2023

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022

National Center for Precision Medicine in Leukemia

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Biobanking
  • (no location specified)
Jun 7, 2022

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

Recruiting
  • Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 20, 2022

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Duarte, California
  • +10 more
Jul 2, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Refractory High Risk Myelodysplastic Syndrome Trial in

Completed
  • Myelodysplastic Syndrome
  • +4 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 11, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue Trial in Houston

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Cognitive Behavior Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia Trial in Tours (Samples, Quality of life questionnaire)

Completed
  • Myelodysplastic Syndrome
  • Secondary Acute Myeloid Leukemia
  • Samples
  • Quality of life questionnaire
  • Tours, France
  • +1 more
Apr 15, 2021

MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

Recruiting
  • Myelodysplastic Syndromes
  • IV Decitabine
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021